Company intelligence / Profile preview

Averto Medical

Fremont, California, United Statesavertomed.com ↗

Ownership: Private
Development stage: Clinical

Overview

Averto Medical is developing the ColoSeal™ Intraluminal Colonic Diversion System, a minimally invasive device designed to eliminate the need for temporary diverting ostomies in colorectal surgeries. The system is currently undergoing clinical evaluation with support from recent Series A financing and an NIH/NCI grant. No commercial or pivotal trial results have been published yet

Therapeutic areas: OncologyGastroenterology
Modalities: Device
Industry: Surgical Medical Devices

Drug pipeline

1 asset

ColoSeal

Clinical

Indications: Colorectal surgery complications

Beyond the preview

Go deeper on Averto Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Averto Medical.

Explore the full profile